【PLABS 0171 交流专区】比德生科

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2017	31 Mar 2016	31 Mar 2017	31 Mar 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	23,109	20,058	23,109	20,058
2	Profit/(loss) before tax	1,258	821	1,258	821
3	Profit/(loss) for the period	882	631	882	631
4	Profit/(loss) attributable to ordinary equity holders of the parent	882	631	882	631
5	Basic earnings/(loss) per share (Subunit)	0.43	0.31	0.43	0.31
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1949		0.1907

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2017	30 Jun 2016	30 Jun 2017	30 Jun 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	23,045	20,004	46,154	40,062
2	Profit/(loss) before tax	1,199	1,192	2,457	2,013
3	Profit/(loss) for the period	963	807	1,845	1,438
4	Profit/(loss) attributable to ordinary equity holders of the parent	963	807	1,845	1,438
5	Basic earnings/(loss) per share (Subunit)	0.46	0.39	0.89	0.70
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2029		0.1907

icy97

EX-date	13 Sep 2017
Entitlement date	15 Sep 2017
Entitlement time	05:00 PM
Entitlement subject	Interim Dividend
Entitlement description	Interim Dividend
Period of interest payment	to
Financial Year End	31 Dec 2017
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHDUnit 32-01, Level 32, Tower A,Vertical Business Suite, Avenue 3, Bangsar South,No. 8, Jalan Kerinchi59200Kuala LumpurTel:0327839299Fax:0327839222
Payment date	10 Oct 2017
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	15 Sep 2017
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.005

icy97

Type	Announcement
Subject	OTHERS
Description	PETERLABS HOLDINGS BERHAD ("PLABS" OR THE "COMPANY")DISTRIBUTOR AGREEMENT BETWEEN PETERLABS SDN BHD, A SUB SUBSIDIARY OF PLABS AND ZOETIS MALAYSIA SDN BHD
The Board of Directors of PLABS wishes to announce that, Peterlabs Sdn Bhd, its sub subsidiary had on 11 October 2017 entered into a distributor agreement with Zoetis Malaysia Sdn Bhd. Please refer to the attachment for the full text of the announcement. This announcement is dated 11 October 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5570121

Attachments PLABS - Annoucement Attachment - Distributor Agreement between PSB and ZMSB.pdf

icy97

Date of change	07 Nov 2017
Name	MR DR GOY HONG BOON
Age	45
Gender	Male
Nationality	Malaysia
Designation	Deputy Chairman
Directorate	Executive
Type of change	Appointment
Qualifications	Bachelor of Business Administration from American Intercontinental University of London (now known as Regents University London) in 1992.MBA (Finance) from Oklahoma City University in 1994. Doctorate in Business Administration from Northwest UniversityMaster of Financial Professional (MFP) certification from American Academy of Financial Management. A member of Chartered Audit Committee Director from The Institute of Internal Auditors Malaysia.
Working experience and occupation	Dr. Goy has vast of experience in the field of equity capital market and information technology sectors. He begins his career in corporate finance with a leading International Investment Bank in 1995, where his last held position as Head of Corporate Finance unit. He then moved on to a leading local securities firm as Vice President for Business Development and Corporate Advisory. Thereafter, he ventured into ICT businesses prior to pursue his profession as consultant and advisor for Mergers & Acquisitions, corporate restructurings and project financing.
Directorships in public companies and listed issuers (if any)	SCC Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer	NIL
Any conflict of interests that he/she has with the listed issuer	NIL
Details of any interest in the securities of the listed issuer or its subsidiaries	Direct interest : NilIndirect interest : 3,466,800 ordinary shares by virtue of his spouse's shareholding in the Company.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2017	30 Sep 2016	30 Sep 2017	30 Sep 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	26,946	20,786	73,100	60,848
2	Profit/(loss) before tax	1,736	1,797	4,193	3,810
3	Profit/(loss) for the period	1,004	1,287	2,849	2,725
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,004	1,287	2,849	2,725
5	Basic earnings/(loss) per share (Subunit)	0.47	0.62	1.35	1.32
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2076		0.1907

icy97

PETERLABS HOLDINGS BERHAD

EX-date	17 Jan 2018
Entitlement date	19 Jan 2018
Entitlement time	05:00 PM
Entitlement subject	Interim Dividend
Entitlement description	Interim Single Tier Dividend of RM0.006 per share
Period of interest payment	to
Financial Year End	31 Dec 2017
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	SHAREWORKS SDN BHDNo. 2-1, Jalan Sri Hartamas 8Sri Hartamas50480 Kuala LumpurWilayah Persekutuan (KL)Tel:03-6201 1120Fax:03-6201 3121
Payment date	09 Feb 2018
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	19 Jan 2018
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	0.006

icy97

Date of change	09 Jan 2018
Name	MR LAU KIN WAI
Age	41
Gender	Male
Nationality	Malaysia
Designation	Executive Director
Directorate	Executive
Type of change	Appointment
Qualifications	Mr Lau Kin Wai graduated first class honors in engineering from the University of Manchester in the United Kingdom and holds a MBA degree from University of Oxford.
Working experience and occupation	Mr Lau is a well-recognised technology entrepreneur in Southeast Asia who founded his first technology company when he was 23 and has since then taken three technology companies public. Mr Lau began his career as the co-founder and Managing Director of Viztel Solutions Berhad (Viztel), a telecom and mobile Internet software startup. By the age of 28 Mr. Lau had led Viztel to IPO and was one of the youngest Managing Directors of a public company in Southeast Asia. In 2007 Mr Lau co-founded Cellsafe Biotech Group, a regional biotechnology business group focusing on non-controversial technologies for harvesting and cryogenic preservation of stem cells. Cellsafe is now a leading stem cell bank network in Southeast Asia, with operations across four countries. Mr Lau is also a Non Executive Director in Sedania Innovator Berhad.
Directorships in public companies and listed issuers (if any)	i. Chairman of iCandy Interactive Limitedii. Executive Director of Fatfish Internet Group Limitediii. Managing Director of Fatfish Global Ventures AB (Sweden)iv. Non Executive Director of Sedania Innovator Berhad
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	16,107,000 ordinary sharesDeemed interest by virtue of his position as Director of Fatfish Ventures Sdn Bhd

icy97

比德生科第2大股東 擬拿下控制權

2018年2月05日
（八打靈再也5日訊）比德生科（PLABS，0171，創業板貿服）第2大股東Fatfish Ventures私人有限公司有意增持股權，並助前者探索新業務和策略商機。

《星報》報導，Fatfish Ventures總執行長劉健偉（譯音）指出，Fatfish Ventures的長期計劃是增持並掌控比德生科。

看好保健和製藥業務

劉健偉是在今年1月初，受委為比德生科執行董事。Fatfish Ventures現為比德生科第2大股東，其母公司是在澳洲股票交易所掛牌上市的Fatfish網絡集團有限公司。

“我們看好比德生科的穩定和獲利的動物保健和製藥業務，年營業額成長介于5%至10%之間。由于食品安全的意識不斷提高，比德生科涉及的業務顯得越來越重要。”

報導指出，劉健偉將為比德生科探索新業務和策略商機，包括能為比德生科帶來新業務成長，又涉及有趣的技術業務。

大馬交易所資料顯示，Fatfish Ventures是在去年4月份通過場外交易，收購比德生科1600萬股，持有7.74%股權，而崛起成為比德生科的主要股東，之后在去年10月12日，又在場外收購比德生科104萬3400股，將持股權提高至7.501%。【中国报财经】

icy97

Type	Announcement
Subject	OTHERS
Description	PETERLABS HOLDINGS BERHAD ("PETERLABS" OR THE "COMPANY")  - THE STARBIZ ARTICLE ENTITLED "PETERLABS CATCHES FATFISH VENTURES"
The Company refers to the article in The Star, Starbiz Section, Page 3 dated 5 February 2018 with regards to the quote of “Peterlabs is aiming to acheive 20% sales growth for 2018”. The Company wishes to clarify that it has been achieving on average 15% growth in revenue for the past 5 years and in particular for the financial year ending 31 December 2018 the management aims to achieve 20% in revenue growth for the year. This aimed revenue growth is a company-wide goal set by the management but the ability to achieve the goal will be subject to prevailing performance of the underlying business operation and relevant market condition of the industry that the Company is in, amongst other macro-economic condition of Malaysia where the Company’s customers are mostly from. The said revenue growth is not a forecast, and has not been reviewed by the external auditors. This announcement is dated 7 February 2018.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2017	31 Dec 2016	31 Dec 2017	31 Dec 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	21,635	22,729	94,735	83,577
2	Profit/(loss) before tax	1,545	1,402	5,738	5,212
3	Profit/(loss) for the period	1,171	610	4,020	3,335
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,171	610	4,020	3,335
5	Basic earnings/(loss) per share (Subunit)	0.55	0.29	1.90	1.61
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2131		0.1907

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2018	31 Mar 2017	31 Mar 2018	31 Mar 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	21,540	23,109	21,540	23,109
2	Profit/(loss) before tax	1,353	1,258	1,353	1,258
3	Profit/(loss) for the period	1,002	882	1,002	882
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,002	882	1,002	882
5	Basic earnings/(loss) per share (Subunit)	0.47	0.43	0.47	0.43
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2117		0.2130

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2018	30 Jun 2017	30 Jun 2018	30 Jun 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	22,490	23,045	44,030	46,154
2	Profit/(loss) before tax	1,141	1,199	2,494	2,457
3	Profit/(loss) for the period	783	963	1,785	1,845
4	Profit/(loss) attributable to ordinary equity holders of the parent	783	963	1,785	1,845
5	Basic earnings/(loss) per share (Subunit)	0.36	0.46	0.83	0.89
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2153		0.2130

icy97

Name	FATFISH VENTURES SDN BHD
Address	2-13A, Sentul East D7 800 Jalan Sentul Kuala Lumpur 51000 Wilayah Persekutuan Malaysia.
Company No.	11068000-P
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	06 Sep 2018	2,900,000	Acquired	Direct Interest
	Name of registered holder	Fatfish Ventures Sdn Bhd
	Address of registered holder	2-13A, Sentul East D7 800 Jalan Sentul 51000 Kuala Lumpur Wilayah Persekutuan (KL)
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquisition of shares through off market
Nature of interest	Direct Interest
Direct (units)	19,801,300
Direct (%)	9.221
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	19,801,300
Date of notice	07 Sep 2018
Date notice received by Listed Issuer	07 Sep 2018

icy97

Type	Announcement
Subject	OTHERS
Description	PETERLABS HOLDINGS BERHAD ("PETERLABS" OR THE "COMPANY")  DISTRIBUTORSHIP AGREEMENT BETWEEN OSMOSIS NUTRITION SDN BHD AND HENAN CHIA TAI BIOCHEMISTRY TRADING CO., LTD
The Board of Directors of Peterlabs wishes to announce that Osmosis Nutrition Sdn Bhd (“ONSB”), its wholly-owned sub-subsidiary had on 7 November 2018 entered into a distributorship agreement with Henan Chia Tai Biochemistry Trading Co., Ltd (“CTB”) for the appointment of CTB as an exclusive distributor to distribute, market, sell and promote ONSB’s Products in the Territory (People’s Republic in China). Please refer to the attachment for the full text of the announcement. This announcement is dated 23 November 2018.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5982985

Attachments Peterlabs - Distributorship Agreement between ONSB and CTB.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2018	30 Sep 2017	30 Sep 2018	30 Sep 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	22,692	26,946	66,722	73,100
2	Profit/(loss) before tax	1,521	1,736	4,015	4,193
3	Profit/(loss) for the period	1,013	1,004	2,798	2,849
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,013	1,004	2,798	2,849
5	Basic earnings/(loss) per share (Subunit)	0.47	0.47	1.30	1.35
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2130

icy97

Type	Announcement
Subject	OTHERS
Description	PETERLABS HOLDINGS BERHAD ("PETERLABS" or the "COMPANY")- REQUISITION PURSUANT TO SECTION 311(3)(a) OF THE COMPANIES 2016 ("CA 2016")- NOTICE OF REQUISITION TO MOVE RESOLUTIONS REQUIRING SPECIAL NOTICE PURSUANT TO SECTIONS 206(3) AND 322 OF THE CA 2016  - NOTICE OF REQUISITION TO MOVE RESOLUTIONS FOR REMOVAL OF DIRECTORS FROM OFFICE AND TO PROPOSE PERSONS FOR ELECTION AS DIRECTORS AND RE-DESIGNATION AS MANAGING DIRECTOR
The Board of Directors' ("Board") the Company wishes to announce that the Company had on 26 February 2019, received a written requisition from the shareholders of the Company holding, in aggregate, more than 10% of the issued share capital of the Company ("Requisitioning Members") to convene an Extraordinary General Meeting pursuant to Section 311 and Section 312 of the Companies Act 2016 in relation to:- a) removing the existing Directors, namely Mr Lim Tong Seng, Dato' Hon Choon Kim, Dr Paul Cheng Chai Liou, Ms Yap Siaw Peng, Mr Lau Yeng Khuan, Dr Vijaya Raghavan A/L M P Nair and Encik Azman bin Abdul Jalil; b) appointing new Directors, namely Ms Chai Choon We, Mr Goh Sim Geh and Mr Cheoh Hor Jin; and c) re-designation of existing Executive Director, Mr Lau Kin Wai to sole Managing Director. The Board of the Company is seeking legal advice on the matter. Further development on the above matter will be announced to Bursa Malaysia Securities Berhad in due course. This announcement is dated 27 February 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6077437

Attachments Peterlabs - Notice of Requisition from Shareholders 26.02.2019.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2018	31 Dec 2017	31 Dec 2018	31 Dec 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	23,697	21,635	90,419	94,735
2	Profit/(loss) before tax	1,515	1,544	5,530	5,737
3	Profit/(loss) for the period	1,087	1,158	3,885	4,007
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,087	1,158	3,885	4,007
5	Basic earnings/(loss) per share (Subunit)	0.51	0.54	1.81	1.89
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2251		0.2130

icy97

Date of change	08 Mar 2019
Name	MR LAU KIN WAI
Age	42
Gender	Male
Nationality	Malaysia
Type of change	Redesignation
Previous Position	Executive Director
New Position	Non-Independent Director
Directorate	Non Independent and Non Executive

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Degree	First Class Honors in Engineering	University of Manchester in the United Kingdom
2	Degree	MBA	University of Oxford

Working experience and occupation	Mr Lau is a well-recognised technology entrepreneur in Southeast Asia who founded his first technology company when he was 23 and has since then taken three technology companies public. Mr Lau began his career as the co-founder and Managing Director of Viztel Solutions Berhad (Viztel), a telecom and mobile Internet software startup. By the age of 28 Mr. Lau had led Viztel to IPO and was one of the youngest Managing Directors of a public company in Southeast Asia. In 2007 Mr Lau co-founded Cellsafe Biotech Group, a regional biotechnology business group focusing on non-controversial technologies for harvesting and cryogenic preservation of stem cells. Cellsafe is now a leading stem cell bank network in Southeast Asia, with operations across four countries. Mr Lau is also a Non Executive Director in Sedania Innovator Berhad.
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	20,847,800 ordinary sharesDeemed interest by virtue of his position as Director of Fatfish Ventures Sdn Bhd

icy97

PETERLABS HOLDINGS BERHAD

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-13032019-00001
Subject	-REQUISITION PURSUANT TO SECTION 311(3)(a) OF THE COMPANIES ACT 2016 ("CA 2016")- NOTICE OF REQUISITION TO MOVE RESOLUTIONS REQUIRING SPECIAL NOTICE PURSUANT TO SECTIONS 206(3) AND 322 OF THE CA 2016- NOTICE OF REQUISITION TO MOVE RESOLUTIONS FOR REMOVAL OF DIRECTORS FROM OFFICE AND TO PROPOSE PERSONS FOR ELECTION AS DIRECTORS AND RE-DESIGNATION AS MANAGING DIRECTOR
Description	PETERLABS HOLDINGS BERHADREPLY TO QUERY
Query Letter Contents	We refer to your Company’s announcement dated 12 March 2019, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1.            The reason for the directors' view that the proposed Extraordinary General Meeting as requisitioned by Fatfish Ventures Sdn Bhd and Hoifutinhong Sdn Bhd  ("Proposed EGM") is not in the best interest of the Company. 2.            The timeframe within which Peterlabs Holdings Berhad ("Peterlabs") is required pursuant to the Companies Act 2016, to call for the Proposed EGM and to hold the Proposed EGM. 3.            The consequences to Peterlabs, if it fails to comply with the timeframe as stated in 2 above.
We refer to the letter dated 13 March 2019 from Bursa Malaysia Securities Berhad with regard to the above, requesting with following additional information for public release. The details of the announcement are set out in the attached file. This announcement is dated 15 March 2019.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6096917

Attachments Peterlabs Holdings Berhad - Reply to Query.pdf